Last updated on November 2017

An Open-Label, Dose-Finding, and Cohort-Expansion Phase 1 Study Evaluating Safety and Efficacy of INCB050465 in Combination With Bendamustine and Obinutuzumab in Subjects With Relapsed or Refractory Follicular Lymphoma (CITADEL-102)


Brief description of study

An Open-Label, Dose-Finding, and Cohort-Expansion Phase 1 Study Evaluating Safety and Efficacy of INCB050465 in Combination With Bendamustine and Obinutuzumab in Subjects With Relapsed or Refractory Follicular Lymphoma (CITADEL-102)

Detailed Study Description

The purpose of this study is to evaluate the safety and tolerability of INCB050465 when combined with bendamustine and obinutuzumab in relapsed or refractory follicular lymphoma (FL).

Clinical Study Identifier: TX14246

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Banner Health

Banner Health
Gilbert, AZ USA
  Connect »

Clinical Research Alliance

Clinical Research Alliance
Lake Success, NY USA
  Connect »

Center for Cancer and Blood ...

Center for Cancer and Blood Disorders
Bethesda, MD USA
  Connect »

Summit Medical Group

Summit Medical Group
Morristown, NJ USA
  Connect »

Greenvile Health System

Greenvile Health System
Greenvile, SC USA
  Connect »

Parc de Salut MAR - ...

Parc de Salut MAR - Hospital del Mar
Barcelona, XX Spain
  Connect »

Hospital Germans Trias i Pujol. ...

Hospital Germans Trias i Pujol. ICO Badalona
Barcelona, XX Spain
  Connect »

Hospital Clínico Universitario de Santiago

Hospital Clínico Universitario de Santiago
A Coruña, XX Spain
  Connect »

Hospital Universitario Fundacin JimZnez D’az

Hospital Universitario Fundacin JimZnez D’az
Madrid, XX Spain
  Connect »

Clinica Universidad de Navarra

Clinica Universidad de Navarra
Navarra, XX Spain
  Connect »

Semmelweis Egyetem I. sz. Belgyogyaszati ...

Semmelweis Egyetem I. sz. Belgyogyaszati Klinika
Budapest, XX Hungary
  Connect »

University of Kansas Cancer Center

University of Kansas Cancer Center
Kansas City, MO USA
  Connect »